In PDAC, the depletion of αSMA+ myofibroblastic CAFs in the pancreas accelerates disease progression, whereas depletion of αSMA+ myofibroblastic MAFs in the liver reduces metastatic disease progression, highlighting organ-specific functional discrepancies among myofibroblasts15,16. Here, ACTA1 is linked to metastatic neoplasm.